TENEKTEPLASE: NEW POSSIBILITIES FOR SYSTEMIC THROMBOLYTIC THERAPY OF ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION
Possibilities to use and advantages of a new tissue plasminogen activator (tenekteplase) in patients with acute coronary syndrome (ACS) with ST segment elevation are discussed. The main factor of tenekteplase successful implementation is the time. Comparative studies of tenekteplase and other tissue...
Saved in:
| Main Authors: | N. A. Novikova, A. E. Udovichenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2016-01-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/929 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of pharmacoinvasive approach to the treatment of patients with ST segment elevation acute coronary syndrome: state of the problem
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01) -
EVOLUTION OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION
by: P. G. Kesov, et al.
Published: (2015-09-01) -
2020 Clinical practice guidelines for Acute ST-segment elevation myocardial infarction
by: (RSC) Russian Society of Cardiology
Published: (2020-12-01) -
Clinical features of the acute period of myocardial infarction with ST segment elevation in patients after reperfusion therapy
by: S. M. Kyselov, et al.
Published: (2020-10-01) -
ROLE OF SYNTAX SCORE SCALE IN THE STRATIFICATION OF THE NOSOCOMIAL RISK OF CARDIOVASCULAR COMPLICATIONS AND LETHALITY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: D. B. Nemik, et al.
Published: (2018-07-01)